Markers of viability and endpoints in ischemic cardiomyopathy.

被引：0
|
作者：
Amanullah, AM [1 ]
Narula, J [1 ]
Dawson, S [1 ]
Guillo, P [1 ]
Heo, J [1 ]
Iskandrian, AE [1 ]
机构：
[1] Hahnemann Univ Hosp, Philadelphia, PA 19102 USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 1999年 / 40卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
738
引用
收藏
页码：162P / 162P
页数：1
相关论文
共 50 条
  • [41] Myocardial viability assessment and utility in contemporary management of ischemic cardiomyopathy
    Katikireddy, Chandra K.
    Samim, Arang
    CLINICAL CARDIOLOGY, 2022, 45 (02) : 152 - 161
  • [42] Viability predicts response to cardiac resynchronization therapy in ischemic cardiomyopathy
    Ypenburg, C.
    Schalij, M. J.
    Bleeker, G. B.
    Steendijk, P.
    Dibbets-Schneider, P.
    Stokkel, M. P. M.
    Van Der Wall, E. E.
    Bax, J. J.
    EUROPEAN HEART JOURNAL, 2006, 27 : 175 - 175
  • [43] Electromechanical mapping for detection of myocardial viability in patients with ischemic cardiomyopathy
    Botker, HE
    Lassen, JF
    Hermansen, F
    Wiggers, H
    Sogaard, P
    Kim, WY
    Bottcher, M
    Thuesen, L
    Pedersen, AK
    CIRCULATION, 2001, 103 (12) : 1631 - 1637
  • [44] MYOCARDIAL VIABILITY ASSESSMENT IN ISCHEMIC CARDIOMYOPATHY - BENEFITS OF CORONARY REVASCULARIZATION
    DREYFUS, GD
    DUBOC, D
    BLASCO, A
    VIGONI, F
    DUBOIS, C
    BRODATY, D
    DELENTDECKER, P
    BACHET, J
    GOUDOT, B
    GUILMET, D
    ANNALS OF THORACIC SURGERY, 1994, 57 (06): : 1402 - 1408
  • [45] MOLECULAR REMODELING OF ION CHANNELS IN HUMAN ATRIAL AND VENTRICULAR MYOCYTES ASSOCIATED WITH ISCHEMIC CARDIOMYOPATHY.
    Gronich, N.
    Kumar, A.
    Zhang, Y.
    Efimov, I. R.
    Soldatov, N. M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 : S43 - S43
  • [46] Pheochromocytoma-induced cardiomyopathy.
    Dale, D
    Matthews, V
    Gomez-Sanchez, C
    JOURNAL OF INVESTIGATIVE MEDICINE, 2006, 54 (01) : S257 - S257
  • [47] Relation between QT dispersion and myocardial viability in ischemic cardiomyopathy
    Schinkel, AFL
    Bountioukos, M
    Poldermans, D
    Elhendy, A
    Valkema, R
    Vourvouri, EC
    Biagini, E
    Rizzello, V
    Kertai, MD
    Krenning, B
    Krenning, EP
    Roelandt, JRTC
    Bax, JJ
    AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (06): : 712 - 715
  • [48] Myocardial Viability and Long-Term Outcomes in Ischemic Cardiomyopathy
    Napp, L. Christian
    Bengel, Frank M.
    Bauersachs, Johann
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (24): : 2373 - 2373
  • [49] Relationship between SYNTAX score and myocardial viability in ischemic cardiomyopathy
    Ozturk, Semi
    Gurbuz, Ahmet Seyfeddin
    Kirma, Cevat
    TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, 2019, 47 (05): : 350 - 356
  • [50] The modern view on diabetic cardiomyopathy.
    Dzhanashiya, P. Kh.
    Mogutova, P. A.
    Poteshkina, N. G.
    CARDIOVASCULAR THERAPY AND PREVENTION, 2010, 9 (02): : 108 - 114
12345